Paradigm Biopharmaceuticals Limited (ASX:PAR)

ASX:PAR Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	15.37	16.82	17.82	56.33	39.67
Short-Term Investments	0.07	-	0.05	0.05	0.05
Cash & Short-Term Investments	15.44	16.82	17.87	56.38	39.72
Cash Growth	-8.17%	-5.87%	-68.31%	41.94%	-44.12%
Other Receivables	13.06	6.37	6.07	6.81	6.72
Receivables	13.06	6.37	6.07	6.81	6.72
Prepaid Expenses	0.64	0.94	1.3	0.6	0.73
Total Current Assets	29.15	24.13	25.24	63.79	47.17
Property, Plant & Equipment	0.5	0.03	0.19	0.34	0.57
Other Intangible Assets	0.91	0.41	2.95	2.95	2.95
Total Assets	30.55	24.57	28.37	67.07	50.69

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	17.15	2.73	2.82	12.16	7.09
Accrued Expenses	0.64	0.49	0.42	0.78	0.59
Short-Term Debt	7	-	-	-	-
Current Portion of Leases	0.15	0.01	0.12	0.1	0.15
Other Current Liabilities	1.65	-	-	-	-
Total Current Liabilities	26.58	3.23	3.36	13.04	7.83
Long-Term Leases	0.36	-	0.12	0.24	0.47
Pension & Post-Retirement Benefits	0.14	0.15	0.11	-	0.08
Other Long-Term Liabilities	-	-	-	0.11	-
Total Liabilities	27.08	3.39	3.58	13.39	8.38

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	289.96	253.23	238.11	209.83	147.19
Retained Earnings	-288.52	-235.95	-219.75	-163.51	-114.02
Comprehensive Income & Other	2.03	3.9	6.42	7.36	9.13
Shareholders' Equity	3.47	21.18	24.79	53.68	42.31
Total Liabilities & Equity	30.55	24.57	28.37	67.07	50.69

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	7.51	0.01	0.24	0.34	0.62
Net Cash (Debt)	7.93	16.81	17.63	56.04	39.1
Net Cash Growth	-52.80%	-4.62%	-68.54%	43.30%	-44.40%
Net Cash Per Share	0.02	0.05	0.06	0.22	0.17
Filing Date Shares Outstanding	599.19	397.43	350.36	281.76	234.25
Total Common Shares Outstanding	584.84	389.43	350.36	281.76	232.68
Working Capital	2.57	20.89	21.88	50.74	39.34
Book Value Per Share	0.01	0.05	0.07	0.19	0.18
Tangible Book Value	2.56	20.77	21.84	50.73	39.37
Tangible Book Value Per Share	0.00	0.05	0.06	0.18	0.17
Machinery	0.05	0.19	0.19	0.19	0.19
Leasehold Improvements	-	0.02	0.02	0.02	0.02

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 10, 2026

Data Sources Report a data error